216 related articles for article (PubMed ID: 19505390)
1. High-dose inhaled flunisolide versus budesonide in the treatment of acute asthma exacerbations in preschool-age children.
Decimo F; Maiello N; Miraglia Del Giudice M; Amelio R; Capristo C; Capristo AF
Int J Immunopathol Pharmacol; 2009; 22(2):363-70. PubMed ID: 19505390
[TBL] [Abstract][Full Text] [Related]
2. Inhaled flunisolide for acute severe asthma.
Rodrigo G; Rodrigo C
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):698-703. PubMed ID: 9517578
[TBL] [Abstract][Full Text] [Related]
3. Corticosteroids administered by nebulization to children with bronchial asthma.
Terzano C; Barkai L; Cremonesi G
Adv Ther; 2001; 18(6):253-60. PubMed ID: 11841195
[TBL] [Abstract][Full Text] [Related]
4. Comparison of efficacy and safety between flunisolide/AeroChamber and budesonide/turbuhaler in patients with moderate asthma. AER-MD-04 Study Group.
Newhouse M; Knight A; Wang S; Newman K
Ann Allergy Asthma Immunol; 2000 Mar; 84(3):313-9. PubMed ID: 10752915
[TBL] [Abstract][Full Text] [Related]
5. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
Berger WE; Noonan MJ
J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
[TBL] [Abstract][Full Text] [Related]
6. Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients.
Corren J; Nelson H; Greos LS; Bensch G; Goldstein M; Wu J; Wang S; Newman K
Ann Allergy Asthma Immunol; 2001 Nov; 87(5):405-11. PubMed ID: 11730183
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy of inhaled fluticasone propionate, 880 microg/day, with flunisolide, 1500 microg/day, in moderate-to-severe persistent asthma.
Sheikh S; Goldsmith LJ; Howell L; Eid N
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):300-4. PubMed ID: 10541421
[TBL] [Abstract][Full Text] [Related]
8. Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma.
Beasley R; Holliday M; Reddel HK; Braithwaite I; Ebmeier S; Hancox RJ; Harrison T; Houghton C; Oldfield K; Papi A; Pavord ID; Williams M; Weatherall M;
N Engl J Med; 2019 May; 380(21):2020-2030. PubMed ID: 31112386
[TBL] [Abstract][Full Text] [Related]
9. Nebulized flunisolide in infants and young children with asthma: a pilot study.
de Benedictis FM; Martinati LC; Solinas LF; Tuteri G; Boner AL
Pediatr Pulmonol; 1996 May; 21(5):310-5. PubMed ID: 8726156
[TBL] [Abstract][Full Text] [Related]
10. Recent trends in the use of inhaled beta 2-adrenergic agonists and inhaled corticosteroids in Saskatchewan.
Habbick B; Baker MJ; McNutt M; Cockcroft DW
CMAJ; 1995 Nov; 153(10):1437-43. PubMed ID: 7585370
[TBL] [Abstract][Full Text] [Related]
11. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A
N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
[TBL] [Abstract][Full Text] [Related]
13. Comparison of high-dose inhaled flunisolide to systemic corticosteroids in severe adult asthma.
Lee-Wong M; Dayrit FM; Kohli AR; Acquah S; Mayo PH
Chest; 2002 Oct; 122(4):1208-13. PubMed ID: 12377843
[TBL] [Abstract][Full Text] [Related]
14. Predictors of severe exacerbations, poor asthma control, and β-agonist overuse for patients with asthma.
Patel M; Pilcher J; Reddel HK; Qi V; Mackey B; Tranquilino T; Shaw D; Black P; Weatherall M; Beasley R;
J Allergy Clin Immunol Pract; 2014; 2(6):751-8. PubMed ID: 25439367
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of inhaled flunisolide versus placebo among asthmatic patients discharged from the emergency department.
Brenner BE; Chavda KK; Camargo CA
Ann Emerg Med; 2000 Nov; 36(5):417-26. PubMed ID: 11054193
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of once-daily dosing of inhaled flunisolide in maintaining asthma control.
ZuWallack RL; Rosen JP; Cohen L; Rachelefsky GS; Gong H; Goldsobel AB; Kaliner MA; White MV; Bronsky EA; Chervinsky P; Lotner GZ; Corren J; Bodenheimer S
J Allergy Clin Immunol; 1997 Mar; 99(3):278-85. PubMed ID: 9058681
[TBL] [Abstract][Full Text] [Related]
17. Early asthma control and maintenance with eformoterol following reduction of inhaled corticosteroid dose.
Price D; Dutchman D; Mawson A; Bodalia B; Duggan S; Todd P;
Thorax; 2002 Sep; 57(9):791-8. PubMed ID: 12200524
[TBL] [Abstract][Full Text] [Related]
18. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma.
Bisgaard H; Le Roux P; Bjåmer D; Dymek A; Vermeulen JH; Hultquist C
Chest; 2006 Dec; 130(6):1733-43. PubMed ID: 17166990
[TBL] [Abstract][Full Text] [Related]
19. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma.
Papi A; Canonica GW; Maestrelli P; Paggiaro P; Olivieri D; Pozzi E; Crimi N; Vignola AM; Morelli P; Nicolini G; Fabbri LM;
N Engl J Med; 2007 May; 356(20):2040-52. PubMed ID: 17507703
[TBL] [Abstract][Full Text] [Related]
20. Effect of short- and long-acting inhaled beta2-agonists on exhaled nitric oxide in asthmatic patients.
Yates DH; Kharitonov SA; Barnes PJ
Eur Respir J; 1997 Jul; 10(7):1483-8. PubMed ID: 9230234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
